Leon van Kempen

Leon van Kempen is an Affiliated Associate Professor at McGill University and a Clinical Scientist in Molecular Pathology, specializing in molecular diagnostic services. His research focuses on the molecular biology and pathology of melanoma and non-small cell lung cancer, with contributions to understanding tumor microenvironments, genetic drivers, and targeted therapies. He collaborates internationally, particularly in studies of fibro-osseous tumors, gastrointestinal stromal tumors, and molecular tumor board applications. Key contributions include developing diagnostic protocols using DNA methylation and next-generation sequencing, and advancing clinical practices through molecular tumor boards. He has led or co-authored over 150 publications and contributed datasets for cBioportal. His work aligns with UN Sustainable Development Goals related to health and innovation.

• External Affiliations: Molecular Diagnostics Services, Tumor Board Initiatives
• Notable Projects: cBioportal MTB (https://cbioportal.health-ri.nl/), NanoString gene expression profiling
• Professional Activities: Speaker at SITC Conferences, Molecular Tumor Board advocacy

Research emphasizes translational applications, including predictive biomarker testing and real-world evidence analysis for cancer treatment efficacy. He actively participates in academic networks, peer reviews, and public engagement through media contributions.